ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Taipei City, TWN:

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Procedure: Sham Comparator
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

Taipei, Taiwan and 87 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Taipei City, Taiwan and 89 other locations

with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...

Enrolling
Diabetes Mellitus
Diabetic Foot Ulcer
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle

Phase 3

Energenesis Biomedical

Taipei, Taiwan and 23 other locations

the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Taipei, Taiwan and 158 other locations

The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes...

Begins enrollment in 6 months
Diabetes Mellitus, Type 2
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 48 other locations

This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Oral semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 96 other locations

double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic...

Enrolling
Diabetic Foot Ulcer
Biological: BB-101

Phase 2

Blue Blood Biotech

Taipei, Taiwan

study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS- 01 as compared to Vehicle in participants with Diabetic...

Active, not recruiting
Diabetic Macular Edema
Drug: Dexamethasone ophthalmic suspension (OCS-01)
Drug: Vehicle

Phase 2, Phase 3

Oculis

Taoyuan District, Taoyuan, Taiwan and 51 other locations

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 164 other locations

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new inv...

Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Cagrilintide

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 197 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems